2023 Women’s Masterclass On Demand
![](https://cme.tarsusmedicaleducation.com/sites/default/files/styles/course_image_teaser/public/course/2023-08/Womens%20Masterclass%20Event%20App%20Icon%20053023-02.jpg?itok=xDjwpSk3)
The recordings from the 2023 Women’s Cardiometabolic Health and Wellness Masterclass are now available. Led by co-chairs Pam R. Taub, MD and Erin D.
Category
- CMHC
Format
- Conference / meeting
- Video
Credits
- 12.00 ACPE Pharmacy
- 12.00 AMA PRA Category 1 Credit™
- 12.00 ANCC
- 12.00 Participation
The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis
![](https://cme.tarsusmedicaleducation.com/sites/default/files/styles/course_image_teaser/public/course/2024-05/Individualizing%20Treatment%20for%20Patients%20with%20Chronic%20Kidney%20050724.ai_1200x630.png?itok=P7wYqiSM)
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects an estimated 25-30% of people in the United States and can often progress to Metabolic dysfunction-associated steatohepatitis (MASH) and cirrhosis.
Category
- CMHC
- TME
Format
- Self-study / Enduring
Credits
- 0.75 ACPE Pharmacy
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
- 0.75 Participation
Exploring Novel Strategies for LDL-C Combination Therapy to Decrease ASCVD Risk: A Paradigm Shift
![](https://cme.tarsusmedicaleducation.com/sites/default/files/styles/course_image_teaser/public/course/2024-05/1682%20Compendium%20052224_1200x630.jpg?itok=2Bud2pqa)
Effectively and safely lowering LDL-C is essential to prevent and reduce the risk of recurrent ASCVD events.
Category
- CMHC
Format
- Self-study / Enduring
Credits
- 1.50 ACPE Pharmacy
- 1.50 AMA PRA Category 1 Credit™
- 1.50 ANCC
- 1.50 CDE
- 1.50 Participation